EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Nefritis túbulo intersticial aguda como causa de insuficiencia renal aguda en un paciente con nefropatía diabética clase III

José Lucas Daza, María Paola Joven Sierra, Camila Alejandra Parra Márquez, Verónica Piedad Remache Otañez, Vanessa Villavicencio Cerón, Ronald Alfredo Cevallos Macías, Otto Javier Intriago Montesdeoca, Miguel Sacoto Mazzini, Marcela Patricia Perero Falcones

Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante · 2025

DOI: 10.56867/120 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Acute tubulointerstitial nephritis (TIN) with eosinophilia and acute tubular injury is a rare but clinically significant cause of acute kidney injury (AKI), especially in patients with chronic comorbidities. Clinical case: A 44-year-old woman with type 2 diabetes, a history of hypertension and a previous episode of diabetic ketoacidosis, was admitted with severe metabolic decompensation secondary to infectious gastroenteritis and dehydration. During her course in the intensive care unit, she developed KDIGO stage III AKI, requiring renal replacement therapy. A kidney biopsy confirmed the diagnosis of acute TIN with tubular injury, attributed to multiple factors: severe hypovolemia, recent exposure to potentially nephrotoxic drugs (allopurinol, antibiotics, and nonsteroidal anti-inflammatory drugs), and gastrointestinal sepsis. Treatment: Treatment included hemodynamic support, insulin therapy, culture-adjusted antibiotics, and intermittent hemodialysis. Outcome: The patient showed metabolic improvement and partial recovery of renal function after three dialysis sessions. Her creatinine level remained at 1.6 mg/dL without requiring hemodialysis. Conclusions: This case presents acute renal deterioration in the context of previously undiagnosed chronic kidney failure. ITN was suspected due to the presence of eosinophiluria, non-nephrotic proteinuria, absence of evident glomerular findings, and exposure to potentially nephrotoxic drugs.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →